Marc Ferrer

6 Patents

• US124350472025

  C-abl Tyrosine Kinase Inhibitory Compound Embodiments and Methods of Making and Using the Same

  Pontifica Universidad Catoclica De Chile

  0 cites
• US122080932025

  Use of Low Dose Emetine for Inhibition of Human Cytomegalovirus (HCMV)

  THE UNITED STATES OF AMERICA, Represented By The Secretary, Department Of Health And Human Services

  0 cites
• US121459222024

  Selective D3 Dopamine Receptor Agonists and Methods of Their Use

  The University Of North Carolina At Chapel Hill

  0 cites
• US117664232023

  2,6-dimethoxy-4-(5-phenyl-4-thiophene-2-yl-1h-imidazol-2-yl)-phenol (DPTIP) a Small Molecule Inhibitor of Neutral Sphingomyelinase 2 (nsmase-2) for the Treatment of Neurodegenerative and Oncologic Diseases

  0 cites
• US116492182023

  C-abl Tyrosine Kinase Inhibitory Compound Embodiments and Methods of Making and Using the Same

  Pontificia Universidad Catolica De Chile

  0 cites
• US116344042023

  Selective D 3 Dopamine Receptor Agonists and Methods of Their Use

  THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL

  0 cites